Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Motor Activity 1Disease 1Depression 1Body Weight Changes 1Body Weight 1Anxiety Disorders 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Professional Autonomy × Clear all
NCT02030353 2016-01-20

The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
35 enrolled
Breast

Body Weight, Body Weight Changes, Breast Neoplasms

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

University of Western Ontario, Canada

Phase 2 Completed
7 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡